EUVIMEDEUVIMED entdecken
Crossref

Synthetic Study towards Providencin: Stereocontrolled Synthesis of the Furan-Substituted Cyclobutanol Segment

Yousuke Yamaoka, Ryo Nishina, Ken-Ichi Fujita, Kiyosei Takasu

Chemical and Pharmaceutical Bulletin · 2024

DOI: 10.1248/cpb.c24-00629 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, 2024. Verfasst von Yousuke Yamaoka und 3 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Kyoto University. Hauptthemen laut MEDLINE: Furans, Diterpenes. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 21 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FuransDiterpenesStereoisomerismCyclobutanesMolecular StructureCycloaddition ReactionCatalysis

Stichwörter der Autor:innen

alkynecycloadditionsmall ring systemterpenoidtotal synthesis

Substanzen

FuransDiterpenescyclobutanolCyclobutanesfuran

Autor:innen und Institutionen

  • Graduate School of Pharmaceutical Sciences, Kyoto University.
  • Graduate School of Human and Environmental Studies, Kyoto University.

Zitieren

APA

Yamaoka, Y., Nishina, R., Fujita, K. I., & Takasu, K. (2024). Synthetic Study towards Providencin: Stereocontrolled Synthesis of the Furan-Substituted Cyclobutanol Segment. Chemical and Pharmaceutical Bulletin. https://doi.org/10.1248/cpb.c24-00629

Vancouver

Yamaoka Y, Nishina R, Fujita KI, Takasu K. Synthetic Study towards Providencin: Stereocontrolled Synthesis of the Furan-Substituted Cyclobutanol Segment. Chemical and Pharmaceutical Bulletin. 2024. doi:10.1248/cpb.c24-00629

BibTeX
@article{Yamaoka2024,
  author = {Yamaoka, Yousuke and Nishina, Ryo and Fujita, Ken-Ichi and Takasu, Kiyosei},
  title = {Synthetic Study towards Providencin: Stereocontrolled Synthesis of the Furan-Substituted Cyclobutanol Segment},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2024},
  doi = {10.1248/cpb.c24-00629}
}
Kostenlos starten →